Worldwide Beta thalassemia Treatment Market Research Report 2021 by Type, Application, Participants and Countries, Forecast Year to 2026
- PRO4358708
- 119 Pages
- March 2021
- Healthcare
Thalassemia, specifically the beta thalassemia disorder, is majorly caused by the mutation within the hemoglobin subunit beta (hbb) gene. for example, at the very least 5.2% of the world populace and also over 7% of expectant ladies have an opportunity to create a beta thalassemia.
Furthermore, beta thalassemia is a blood illness that lowers the manufacturing of hemoglobin. in people with beta thalassemia, low levels of hemoglobin trigger a deficiency of oxygen in numerous parts of the body.
Influenced individuals also have a scarcity of red blood cells (anemia) that causes light skin, weak point, fatigue, and also more severe difficulties. individuals with beta thalassemia go to the danger of developing abnormal blood embolisms.
Beta thalassemia treatment market: motorists and also restrictions
Boosting frequency of the condition worldwide with none feasible therapy options available for treating the illness; this factor is expected to drive the beta thalassemia therapy market development. additionally, growth within the evolution of pipeline drugs as well as also the development of the most up to date treatments as a result of r& d tasks and also financial investments by the different authorities.
On the other hand, boosting understanding pertaining to offered treatment alternatives for the treatment of thalassemia is anticipated to drive the expansion of the beta thalassemia treatment market. in addition, the rise popular for improved alleviative gene therapy is forecasted to drive the development of the beta thalassemia treatment market.
Lack of viable treatment alternatives commercialized for the therapy of condition instead of the signs associated with the disease; this element is approximated to limit the beta thalassemia therapy market development. nevertheless, the high price of treatment for the condition is hindering the beta thalassemia treatment market growth.
Beta thalassemia therapy market: introduction
The worldwide beta thalassemia treatment market is approximated to experience significant growth throughout the projection period. large population, boost in recognition concerning available therapy choices, and rise sought after for improved alleviative gene treatments are a range of the lucrative elements estimated for the more development of the beta thalassemia treatment market
Thalassemia is an unusual genetic blood disorder identified by the production of unusual hemoglobin, which is in charge of the damage of red blood cells, causing anemia.
Blood transfusion as well as iron chelation therapies are the only genuine treatment alternatives offered nowadays. this supplies surge to enough opportunities within the market for the occasion of a global alleviative therapy for thalassemia.
Beta thalassemia treatment market: local sensible overview
Geographically, the beta thalassemia therapy market is segmented into 7 areas viz. south Asia, eastern Asia, Europe, Latin America, north America, oceania, and the center east and also Africa.
North America is prepared for to dominate the overall thalassemia therapy market followed by Europe, Asia-pacific, as well as middle east & Africa. the north America region is approximated to have a considerable share in the beta thalassemia therapy market owing to the presence of principals, high prevalence of thalassemia individuals within the region, as well as developed medical care infrastructure.
Additionally, beneficial government initiatives and also a rise in the number of research study collaborations are some vehicle drivers approximated to prolong the beta thalassemia therapy market growth.
Furthermore, in Europe, the intro of genetics treatment for the treatment of thalassemia is anticipated to boost the growth of the beta thalassemia therapy market. at the same time, Asia pacific is the fastest-growing local market in beta thalassemia therapy owing to the high investment in healthcare framework is expected to drive the development of the beta thalassemia therapy market in this region.
The key participants running in the international beta thalassemia therapy market are
Bluebird bio, inc.
Acceleron pharma, inc.
Celgene corporation
Glaxosmithkline plc
Incyte corporation
Gamida cell
Kiadis pharma
La jolla pharmaceutical business
Ionis drugs
Apopharma inc.
Major firms are concentrating on mergings and also procurements, new product growths, approvals, and also local developments. as an example, in september 2019, bluebird biography, inc. (us) has actually approved the main genetics treatment for beta thalassemia treatment.
This genetics therapy decreases the demand for blood transfusions in clients with beta thalassemia. hence, most of suppliers are concentrating on approvals for beta thalassemia that eventually drives the expansion of the beta thalassemia therapy market.
The record is a compilation of first-hand information, qualitative as well as quantitative evaluation by sector analysts, inputs from market specialists, and also sector individuals across the value chain.
The report supplies an in-depth evaluation of parent market patterns, macro-economic indicators, and regulating elements in addition to market appearance as per segments. the record also maps the qualitative influence of various market elements on market sectors as well as locations.
Market sectors
Market characteristics
Market dimension
Supply & need present trends/issues/challenges
Competition & firms involved
Modern technology matrix
Worth chain
The local analysis of the beta thalassemia therapy market record includes
North America
Latin America
Europe
Southern Asia
Eastern Asia
Oceania
The middle east as well as Africa
Beta thalassemia treatment market report highlights:
Overview of the global medical care market
Evolution of the innovation
Changing market dynamics in the sector
Thorough market division
Historical, present and projected market size in regards to worth
Current sector trends and also advancements
Competitive landscape
Techniques of principals and items supplied
Prospective and particular niche sectors, geographical areas displaying encouraging development
A neutral point of view on market performance
Must-have details for market gamers to maintain and also boost their market impact.
Beta thalassemia therapy market: segmentation
Tentatively, the international beta thalassemia treatment market has been segmented based on item type, distribution channels, as well as location.
By therapy
Blood transfusions
Iron chelation treatment
Folic acid supplements
Genetics treatment
Bone marrow transplants
By distribution channel
Healthcare facility pharmacies
Retail pharmacies
Online drug stores
1. Introduction
1.1 Definition of the Market
1.2 Research Purpose
1.3 Scope of the Study
1.4 Stakeholders
1.5 Geography Coverage
1.6 Currency Under Consideration
1.7 Volume Units
1.8 Review Cycle
1.9 Summary and Key Findings of the Research
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach (Involves time, Space, and Persons)
2.3 Data Triangulation
2.4 Assumptions
2.5 Hypothesis of this Research, Clear, specific, and testable statement of this research
2.6 Limitations of Our Study
2.7 Scene Based Modeling
2.8 Covid-19 Impact/Evaluation
3. Market Dynamics
3.1 Driving Factors
3.1.1 Rising Demand in one or More of the Following Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
3.1.2 Increasing Use of Beta thalassemia Treatment by Different End-User/Applications
3.2 Restraints and Challenges in the Market
3.3 Opportunities
4. Global Beta thalassemia Treatment Market-Segmentation
4.1 By Type
…
4.2 By End-User/Application Industry
…
4.3 By Geography
4.3.1 North America Beta thalassemia Treatment Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.1.1 North America Beta thalassemia Treatment Production from 2014-2020
4.3.1.2 North America Beta thalassemia Treatment Consumption from 2014-2020
4.3.1.3 North America Beta thalassemia Treatment Import and Export from 2014-2020
4.3.1.4 North America Beta thalassemia Treatment Market Value ($) and Growth (%) by Type from 2019-2020
4.3.1.5 North America Beta thalassemia Treatment Market Value ($) and Growth (%) by Application from 2019-2020
4.3.1.6 North America Beta thalassemia Treatment Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.1.7 Top North America Beta thalassemia Treatment Participants Value ($) and Market Share (%) in 2020
4.3.2 Europe Beta thalassemia Treatment Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.2.1 Europe Beta thalassemia Treatment Production from 2014-2020
4.3.2.2 Europe Beta thalassemia Treatment Consumption from 2014-2020
4.3.2.3 Europe Beta thalassemia Treatment Import and Export from 2014-2020
4.3.2.4 Europe Beta thalassemia Treatment Market Value ($) and Growth (%) by Type from 2019-2020
4.3.2.5 Europe Beta thalassemia Treatment Value ($) and Growth (%) by Application from 2019-2020
4.3.2.6 Europe Beta thalassemia Treatment Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.2.7 Top Europe Beta thalassemia Treatment Participants Value ($) and Market Share (%) in 2020
4.3.3 Asia-Pacific Beta thalassemia Treatment Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.3.1 Asia-Pacific Beta thalassemia Treatment Production from 2014-2020
4.3.3.2 Asia-Pacific Beta thalassemia Treatment Consumption from 2014-2020
4.3.3.3 Asia-Pacific Beta thalassemia Treatment Import and Export from 2014-2020
4.3.3.4 Asia-Pacific Beta thalassemia Treatment Value ($) and Growth (%) by Type from 2019-2020
4.3.3.5 Asia-Pacific Beta thalassemia Treatment Value ($) and Growth (%) by Application from 2019-2020
4.3.3.6 Asia-Pacific Beta thalassemia Treatment Value ($) and Growth (%) by Countries from 2019-2020
4.3.3.7 Top Asia-Pacific Beta thalassemia Treatment Participants Value ($) and Market Share (%) in 2020
4.3.4 Latin America Beta thalassemia Treatment Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.4.1 Latin America Beta thalassemia Treatment Production from 2014-2020
4.3.4.2 Latin America Beta thalassemia Treatment Consumption from 2014-2020
4.3.4.3 Latin America Beta thalassemia Treatment Import and Export from 2014-2020
4.3.4.4 Latin America Beta thalassemia Treatment Value ($) and Growth (%) by Type from 2019-2020
4.3.4.5 Latin America Beta thalassemia Treatment Value ($) and Growth (%) by Application from 2019-2020
4.3.4.6 Latin America Beta thalassemia Treatment Value ($) and Growth (%) by Countries from 2019-2020
4.3.4.7 Top Latin America Beta thalassemia Treatment Participants Value ($) and Market Share (%) in 2020
4.3.5 Middle East & Africa Beta thalassemia Treatment Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.5.1 Middle East & Africa Beta thalassemia Treatment Production from 2014-2020
4.3.5.2 Middle East & Africa Beta thalassemia Treatment Consumption from 2014-2020
4.3.5.3 Middle East & Africa Beta thalassemia Treatment Import and Export from 2014-2020
4.3.5.4 Middle East & Africa Beta thalassemia Treatment Value ($) and Growth (%) by Type from 2019-2020
4.3.5.5 Middle East & Africa Beta thalassemia Treatment Value ($) and Growth (%) by Application from 2019-2020
4.3.5.6 Middle East & Africa Beta thalassemia Treatment Value ($) and Growth (%) by Countries from 2019-2020
4.3.5.7 Top Middle East & Africa Beta thalassemia Treatment Participants Value ($) and Market Share (%) in 2020
5. Global Level Competitive Intelligence – Company Profiles
5.1 Company one
5.1.1 Company one Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.1.2 Company one Sales, Growth Rate and Global Market Share from 2014-2020
5.2 Company two
5.2.1 Company two Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.2.2 Company two Sales, Growth Rate and Global Market Share from 2014-2020
5.3 Company three
5.3.1 Company three Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.3.2 Company three Sales, Growth Rate and Global Market Share from 2014-2020
5.4 Company four
5.4.1 Company four Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.4.2 Company four Sales, Growth Rate and Global Market Share from 2014-2020
5.5 Company five
5.5.1 Company five Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.5.2 Company five Sales, Growth Rate and Global Market Share from 2014-2020
5.6 Company six
5.6.1 Company six Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.6.2 Company six Sales, Growth Rate and Global Market Share from 2014-2020
5.7 Company seven
5.7.1 Company seven Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.7.2 Company seven Sales, Growth Rate and Global Market Share from 2014-2020
5.8 Company eight
5.8.1 Company eight Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.8.2 Company eight Sales, Growth Rate and Global Market Share from 2014-2020
5.9 Company nine
5.9.1 Company nine Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.9.2 Company nine Sales, Growth Rate and Global Market Share from 2014-2020
5.10 Company ten
5.10.1 Company ten Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.10.2 Company ten Sales, Growth Rate and Global Market Share from 2014-2020
5.11 Company 11
5.11.1 Company 11 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.11.2 Company 11 Sales, Growth Rate and Global Market Share from 2014-2020
5.12 Company 12
5.12.1 Company 12 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.12.2 Company 12 Sales, Growth Rate and Global Market Share from 2014-2020
5.13 Company 13
5.13.1 Company 13 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.13.2 Company 13 Sales, Growth Rate and Global Market Share from 2014-2020
5.14 Company 14
5.14.1 Company 14 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.14.2 Company 14 Sales, Growth Rate and Global Market Share from 2014-2020
5.15 Company 15
5.15.1 Company 15 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.15.2 Company 15 Sales, Growth Rate and Global Market Share from 2014-2020
...
6. Investment Analysis
6.1 Fundamental Analysis (Porter's Five Forces Analysis)
6.2 Technical Preparation Analysis
6.3 Risk Evaluating Analysis
6.4 Estimated Investment Pay-Back Period
7. Future Forecast of Global Beta thalassemia Treatment Market from 2020-2026
7.1 Future Forecast of Global Beta thalassemia Treatment Market from 2020-2026 Segment by Regions
7.2 Future Forecast of Global Beta thalassemia Treatment Market from 2020-2026 Segment by Type
7.3 Future Forecast of Global Beta thalassemia Treatment Market from 2020-2026 Segment by Application
8 Appendix
8.1 Discussion Guide
8.2 Related Reports
8.3 Author List
835 Disclaimer
Table Key Data from Secondary Sources
Table Key Data Parameter
Figure Market Size Estimation by End-Use Industry
Figure Market: Data Triangulation
Figure Market Size Estimation: Top-Down Approach
Table Driving Factors for this Market (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa)
Table Global Beta thalassemia Treatment Production and Growth Rate Segment by Product Types from 2014-2020
Table Global Beta thalassemia Treatment Value ($) and Growth Rate Segment by Product Types from 2014-2020
Figure Type 1 of Beta thalassemia Treatment
Figure Type 2 of Beta thalassemia Treatment
Figure Type 3 of Beta thalassemia Treatment
Table Global Beta thalassemia Treatment Consumption and Growth Rate Segment by End-User/Application from 2014-2020
Table Global Beta thalassemia Treatment Value ($) and Growth Rate Segment by End-User/Application from 2014-2020
Figure Application 1 of Beta thalassemia Treatment
Figure Application 2 of Beta thalassemia Treatment
Figure Application 3 of Beta thalassemia Treatment
Table Global Beta thalassemia Treatment Production Value ($) by Regions
Table Global Beta thalassemia Treatment Production Value Share by Regions
Table Global Beta thalassemia Treatment Production by Regions
Table Global Beta thalassemia Treatment Production Share by Regions
Table Global Beta thalassemia Treatment Consumption by Regions
Table Global Beta thalassemia Treatment Consumption Share by Regions
Figure North America Beta thalassemia Treatment Production and Growth Rate from 2014-2020
Figure North America Beta thalassemia Treatment Consumption and Growth Rate from 2014-2020
Table North America Beta thalassemia Treatment Import and Export from 2014-2020
Table North America Beta thalassemia Treatment Value ($) and Growth (%) by Type from 2019-2020
Table North America Beta thalassemia Treatment Value ($) and Growth (%) by Application from 2019-2020
Table North America Beta thalassemia Treatment Value ($) and Growth (%) by Countries from 2019-2020
Table Top North America Beta thalassemia Treatment Participants Value ($) and Market Share (%) in 2020
Figure Europe Beta thalassemia Treatment Production and Growth Rate from 2014-2020
Figure Europe Beta thalassemia Treatment Consumption and Growth Rate from 2014-2020
Table Europe Beta thalassemia Treatment Import and Export from 2014-2020
Table Europe Beta thalassemia Treatment Value ($) and Growth (%) by Type from 2019-2020
Table Europe Beta thalassemia Treatment Value ($) and Growth (%) by Application from 2019-2020
Table Europe Beta thalassemia Treatment Market Value ($) and Growth (%) by Countries from 2019-2020
Table Top Europe Beta thalassemia Treatment Participants Value ($) and Market Share (%) in 2020
Figure Asia-Pacific Beta thalassemia Treatment Production and Growth Rate from 2014-2020
Figure Asia-Pacific Beta thalassemia Treatment Consumption and Growth Rate from 2014-2020
Table Asia-Pacific Beta thalassemia Treatment Import and Export from 2014-2020
Table Asia-Pacific Beta thalassemia Treatment Value ($) and Growth (%) by Type from 2019-2020
Table Asia-Pacific Beta thalassemia Treatment Value ($) and Growth (%) by Application from 2019-2020
Table Asia-Pacific Beta thalassemia Treatment Value ($) and Growth (%) by Countries from 2019-2020
Table Top Asia-Pacific Beta thalassemia Treatment Participants Value ($) and Market Share (%) in 2020
Figure Latin America Beta thalassemia Treatment Production and Growth Rate from 2014-2020
Figure Latin America Beta thalassemia Treatment Consumption and Growth Rate from 2014-2020
Table Latin America Beta thalassemia Treatment Import and Export from 2014-2020
Table Latin America Beta thalassemia Treatment Value ($) and Growth (%) by Type from 2019-2020
Table Latin America Beta thalassemia Treatment Value ($) and Growth (%) by Application from 2019-2020
Table Latin America Beta thalassemia Treatment Value ($) and Growth (%) by Countries from 2019-2020
Table Top Latin America Beta thalassemia Treatment Participants Value ($) and Market Share (%) in 2020
Figure Middle East & Africa Beta thalassemia Treatment Production and Growth Rate from 2014-2020
Figure Middle East & Africa Beta thalassemia Treatment Consumption and Growth Rate from 2014-2020
Table Middle East & Africa Beta thalassemia Treatment Import and Export from 2014-2020
Table Middle East & Africa Beta thalassemia Treatment Value ($) and Growth (%) by Type from 2019-2020
Table Middle East & Africa Beta thalassemia Treatment Value ($) and Growth (%) by Application from 2019-2020
Table Middle East & Africa Beta thalassemia Treatment Value ($) and Growth (%) by Countries from 2019-2020
Table Top Middle East & Africa Beta thalassemia Treatment Participants Value ($) and Market Share (%) in 2020
Table Company one Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company one Sales and Growth Rate from 2014-2020
Figure Company one Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company two Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company two Sales and Growth Rate from 2014-2020
Figure Company two Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company three Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company three Sales and Growth Rate from 2014-2020
Figure Company three Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company four Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company four Sales and Growth Rate from 2014-2020
Figure Company four Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company five Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company five Sales and Growth Rate from 2014-2020
Figure Company five Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company six Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company six Sales and Growth Rate from 2014-2020
Figure Company six Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company seven Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company seven Sales and Growth Rate from 2014-2020
Figure Company seven Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company eight Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company eight Sales and Growth Rate from 2014-2020
Figure Company eight Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company nine Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company nine Sales and Growth Rate from 2014-2020
Figure Company nine Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company ten Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company ten Sales and Growth Rate from 2014-2020
Figure Company ten Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 11 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 11 Sales and Growth Rate from 2014-2020
Figure Company 11 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 12 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 12 Sales and Growth Rate from 2014-2020
Figure Company 12 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 13 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 13 Sales and Growth Rate from 2014-2020
Figure Company 13 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 14 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 14 Sales and Growth Rate from 2014-2020
Figure Company 14 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 15 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 15 Sales and Growth Rate from 2014-2020
Figure Company 15 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Global Beta thalassemia Treatment Value ($) and Growth Rate Forecast by Regions (2020-2026)
Table Global Beta thalassemia Treatment Production and Growth Rate Forecast by Regions (2020-2026)
Table Global Beta thalassemia Treatment Consumption and Growth Rate Forecast by Regions (2020-2026)
Table Global Beta thalassemia Treatment Production and Growth Rate Forecast by Types (2020-2026)
Table Global Beta thalassemia Treatment Consumption and Growth Rate Forecast by End-User/Applications (2020-2852)
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
